Status:

COMPLETED

The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups

Lead Sponsor:

Gulhane School of Medicine

Conditions:

Secondary Hypogonadism

Eligibility:

MALE

Phase:

PHASE4

Brief Summary

The study is designed to answer the following questions: 1. Is there any difference between the compositions of the HDL cholesterol subpopulations of patients with hypogonadism and the healthy contro...

Detailed Description

This study has two designs: 1. The case control design to search for the difference between the HDL subgroups and the other metabolic parameters between the healthy subjects and the patients with hyp...

Eligibility Criteria

Inclusion

  • Congenital hypogonadotrophic hypogonadism,
  • Male sex

Exclusion

  • Previous history of androgen replacement,
  • any chronic disorder

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2011

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT01454011

Start Date

September 1 2008

End Date

February 1 2011

Last Update

October 18 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gulhane School of Medicine

Ankara, Turkey (Türkiye), 06018

The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups | DecenTrialz